The latest closing stock price for Mineralys Therapeutics as of November 22, 2024 is 12.49.
An investor who bought $1,000 worth of Mineralys Therapeutics stock at the IPO in 2023 would have $-323 today, roughly 0 times their original investment - a -17.70% compound annual growth rate over 2 years.
The all-time high Mineralys Therapeutics stock closing price was 19.14 on March 03, 2023.
The Mineralys Therapeutics 52-week high stock price is 16.91, which is 35.4% above the current share price.
The Mineralys Therapeutics 52-week low stock price is 6.12, which is 51% below the current share price.
The average Mineralys Therapeutics stock price for the last 52 weeks is 12.04.
An investor who bought $1,000 worth of Mineralys Therapeutics stock at the IPO in 2023 would have $-323 today, roughly 0 times their original investment - a -17.70% compound annual growth rate over 2 years.
The all-time high Mineralys Therapeutics stock closing price was 19.14 on March 03, 2023.
The Mineralys Therapeutics 52-week high stock price is 16.91, which is 35.4% above the current share price.
The Mineralys Therapeutics 52-week low stock price is 6.12, which is 51% below the current share price.
The average Mineralys Therapeutics stock price for the last 52 weeks is 12.04.